R. Masse et La. Wright, PROPOSED DEFINITIVE METHODS FOR MEASUREMENT OF PLASMA TESTOSTERONE AND 17-ALPHA-HYDROXYPROGESTERONE, Clinical biochemistry, 29(4), 1996, pp. 321-331
Objectives: This report provides the results of the development and ev
aluation of definitive isotope dilution/mass spectrometry (ID/MS) meth
ods for the determination of testosterone and 17 alpha-hydroxyprogeste
rone in human plasma at concentrations ranging from 1.4 to 37.9 nmol/L
and 1.5 to 45.4 nmol/L, respectively. The internal standards were 16,
16,17-H-2-testosterone and 21,21,21,-H-2-17 alpha-hydroxyprogesterone.
The development of optimum extraction and derivatization procedures,
and studies of storage time, temperature effects, accuracy, and precis
ion are presented. Results: The results indicate that the methods empl
oying the TBDMS derivative of testosterone and MO-TMS derivative of 17
alpha-hydroxyprogesterone are capable of generating accurate and prec
ise data at the inherently low concentrations given, with recovery gre
ater than 95%. Accuracy of testosterone in the fortified steroid-free
and pooled plasma by ID/MS measurement was good because the relative e
rror ranged from +3.1% to -0.7, with a mean of 0.9% over the concentra
tion levels of 1.4 to 37.9 nmol/L testosterone, and the imprecision ra
nged from 4.2% to 0.7% CV, with a mean of 1.9%. Accuracy of 17 alpha-h
ydroxyprogesterone in the fortified steroid-free and pooled plasma was
also good, considering the inherently low concentrations. The relativ
e error ranged from -2.1% to +1.5%, with a mean of 1.1%, and the impre
cision ranged from 3.8% to 0.8% CV with a mean of 1.3% over concentrat
ion levels of 1.5 to 15.1 nmol/L. The high precision and accuracy and
absence of statistically significant bias qualifies these methods as c
andidate definitive methods for plasma testosterone and 17 alpha-hydro
xyprogesterone.